Mar 07, 2023

If You Have a Horse, You Have an Athlete: Tips for Managing Degenerative Joint Disease in Your Equine Athlete

By Adequan - Sponsor
Image courtesy of American Regent, Inc.

Estimates indicate up to 60 percent of lameness in the horse is related to end-stage degenerative joint disease (DJD), also known as osteoarthritis (OA). DJD can influence performance and significantly impact any horse—from top competitors and weekend warriors to aging seniors.

Daily training, competition, and riding, not to mention age-related degenerative processes, can all lead to a disruption in a healthy joint’s natural wear and repair cycle. Your veterinarian can help by observing the signs of DJD in your horse, diagnosing the disease early and starting treatment with a product that treats the disease, not just the clinical signs.

For over 30 years, Adequan® i.m. (polysulfated glycosaminoglycan) has been used millions of times by leading veterinarians2 because it is proven to help: reduce inflammation, restore synovial joint lubrication, repair joint cartilage and reverse the disease process.3,4 It’s a powerful tool in the fight against equine DJD.

Six tips for managing OA in your horse:

  • Maintain your horse’s healthy weight—excess weight can put considerable stress on joints
  • Encourage regular exercise—activity is essential for a horse’s healthy joints
  • Allow appropriate cooling out after vigorous exercise
  • Provide balanced nutrition, especially during the growth phase
  • Schedule regular veterinary well-checks—monitoring for signs of osteoarthritis allows your veterinarian to make an early diagnosis and start treatment before the disease worsens or becomes irreversible
  • Ask your veterinarian about Adequan i.m.—the only FDA-approved polysulfated glycosaminoglycan (PSGAG) and an important first-line treatment for DJD because of its ability to produce disease-modifying effects5

Discover if Adequan® i.m. is the right choice for your horse. Visit adequan.com for more information.

INDICATIONS

Adequan® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

IMPORTANT SAFETY INFORMATION There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For full prescribing information, visit adequan.com.

1 McIlwraith CW, Frisbie DD, Kawcak CE, van Weeren PR. Joint Disease in the Horse. St. Louis, MO: Elsevier, 2016; 33-48.
2 Data on File, American Regent Animal Health, Inc.
3 Burba DJ, Collier MA, DeBault LE, Hanson-Painton O, Thompson HC, Holder CL: In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondraldefect model. J Equine Vet Sci 1993; 13: 696-703.
4 Adequan® i.m. Package Insert, REV 1/19.
5 McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res 2012; 1: 297-309.
All trademarks are the property of American Regent, Inc.
© 2022, American Regent, Inc. PP-AI-US-0772 5/2022
Apr 25, 2025 Competitions

2025 K3DE Rider Talk: What Are They Saying About Cross-Country?

Riders in both the Cosequin Lexington CCI4*-S and the Defender Kentucky CCI5*-L are sharing similar sentiments about this year's cross-country courses: course designer Derek di Grazia didn't play around this year. Here is what some of the riders across both divisions had to say about the tracks they will aim to conquer on Saturday.

Apr 25, 2025 Competitions

Off the Record Breaks Records in Cosequin Lexington CCI4*-S at Defender Kentucky

Off The Record decided not to let Michael Jung be the only record-breaking entry at the Defender Kentucky Three-Day Event this week and delivered a career-best score in the Cosequin Lexington CCI4*-S on Friday morning. He and Will Coleman delivered a test that received a score of 21.8, not only marking a personal best for the horse but also securing their position at the top of the leaderboard going into cross-country tomorrow.

Apr 25, 2025 Competitions

Soaked, but Not Shaken: Boyd Martin Flies the Flag for the U.S. at Defender Kentucky in Second

Boyd Martin and the 12-year-old Holsteiner gelding Commando 3 were the last pair to go in the Defender Kentucky CCI5*-L field on Friday afternoon and were warmly greeted to the bluegrass with an impressive downpour that outshined anything the other horse and rider pairs had to combat throughout the day. But that didn’t stop this pair from putting their best foot forward and impressing the judges enough to earn them a score of 26.0, just 0.2 points ahead of second-place pair Tom McEwen (GBR) and Brookfield Quality.

Apr 25, 2025 Association News

Beware of Phishing Attempts and Other Types of Fraud

Please always remain vigilant when it comes to sending any personal communications via email or text. Every year we receive reports of members and leaders of our sport receiving phishing attempts both online and by phone. These are often communications disguised as being sent from USEA staff or other leaders. As the years go on, the phishing attempts appear to be more directed and tailored.

Official Corporate Sponsors of the USEA

Official Joint Therapy Treatment of the USEA

Official Feed of the USEA

Official Saddle of the USEA

Official Forage of the USEA

Official Competition & Training Apparel of the USEA

Official Horse Boot of the USEA

Official Shock Wave of the USEA

Official Horse Wear of the USEA